Loading…
Smokalo, Inc. manufactured and distributed e-liquid tobacco products without obtaining required premarket authorization from the FDA, in violation of the Family Smoking Prevention and Tobacco Control Act. The company's e-liquid products, classified as newly deemed tobacco products subject to FDA jurisdiction since August 2016, were being offered for commercial sale in the United States without the mandated marketing authorization orders for new tobacco products as defined under section 910 of the Federal Food, Drug, and Cosmetic Act. The FDA's inspection records and review of the company's submissions determined that Smokalo failed to comply with applicable tobacco product regulations governing e-cigarettes and related nicotine delivery systems.